Titan Biotech Past Earnings Performance
Past criteria checks 3/6
Titan Biotech has been growing earnings at an average annual rate of 23.7%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 16.5% per year. Titan Biotech's return on equity is 20.5%, and it has net margins of 15.4%.
Key information
23.7%
Earnings growth rate
23.8%
EPS growth rate
Chemicals Industry Growth | 17.7% |
Revenue growth rate | 16.5% |
Return on equity | 20.5% |
Net Margin | 15.4% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Titan Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 1,610 | 248 | 250 | 0 |
30 Sep 23 | 1,453 | 209 | 236 | 0 |
30 Jun 23 | 1,447 | 229 | 223 | 0 |
31 Mar 23 | 1,440 | 248 | 210 | 0 |
31 Dec 22 | 1,403 | 249 | 180 | 0 |
30 Sep 22 | 1,464 | 268 | 174 | 0 |
30 Jun 22 | 1,500 | 249 | 173 | 0 |
31 Mar 22 | 1,235 | 217 | 149 | 0 |
31 Dec 21 | 1,538 | 241 | 165 | 0 |
30 Sep 21 | 1,525 | 255 | 161 | 0 |
30 Jun 21 | 1,443 | 263 | 148 | 0 |
31 Mar 21 | 1,422 | 303 | 146 | 0 |
31 Dec 20 | 1,268 | 285 | 152 | 0 |
30 Sep 20 | 1,109 | 236 | 148 | 0 |
30 Jun 20 | 968 | 178 | 126 | 0 |
31 Mar 20 | 794 | 71 | 143 | 0 |
31 Dec 19 | 766 | 58 | 135 | 0 |
30 Sep 19 | 728 | 49 | 125 | 0 |
30 Jun 19 | 713 | 46 | 108 | 0 |
31 Mar 19 | 649 | 35 | 117 | 0 |
31 Dec 18 | 659 | 46 | 61 | 0 |
30 Sep 18 | 662 | 41 | 58 | 0 |
30 Jun 18 | 627 | 34 | 36 | 0 |
31 Mar 18 | 574 | 25 | 86 | 0 |
31 Dec 17 | 587 | 27 | 73 | 0 |
30 Sep 17 | 557 | 22 | 67 | 0 |
30 Jun 17 | 535 | 23 | 50 | 0 |
31 Mar 17 | 527 | 22 | 39 | 0 |
31 Dec 16 | 503 | 18 | 48 | 0 |
30 Sep 16 | 494 | 20 | 46 | 0 |
30 Jun 16 | 484 | 18 | 37 | 0 |
31 Mar 16 | 458 | 18 | 42 | 0 |
31 Dec 15 | 451 | 16 | 65 | 0 |
30 Sep 15 | 419 | 16 | 64 | 0 |
30 Jun 15 | 408 | 16 | 28 | 0 |
31 Mar 15 | 403 | 16 | 32 | 0 |
31 Dec 14 | 395 | 16 | 60 | 0 |
30 Sep 14 | 405 | 16 | 59 | 0 |
30 Jun 14 | 415 | 15 | 24 | 0 |
31 Mar 14 | 391 | 15 | 56 | 0 |
31 Dec 13 | 355 | 15 | 45 | 0 |
30 Sep 13 | 329 | 13 | 44 | 0 |
30 Jun 13 | 278 | 13 | 18 | 0 |
Quality Earnings: 524717 has high quality earnings.
Growing Profit Margin: 524717's current net profit margins (15.4%) are lower than last year (17.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 524717's earnings have grown significantly by 23.7% per year over the past 5 years.
Accelerating Growth: 524717's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 524717 had negative earnings growth (-0.3%) over the past year, making it difficult to compare to the Chemicals industry average (-6.1%).
Return on Equity
High ROE: 524717's Return on Equity (20.5%) is considered high.